ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS



The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.



 Key Statistics


Email: contactus@themedco.com
Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO
 





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient

Alnylam 





 Company News
The Medicines Company (MDCO) To Participate In The Jefferies and Co. 2015 Healthcare Conference 5/22/2015 6:38:31 AM
The Medicines Company (MDCO) To Participate In Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/8/2015 11:35:17 AM
The Medicines Company (MDCO) Reports First Quarter 2015 Financial Results And Operational Developments 5/5/2015 11:40:53 AM
The Medicines Company (MDCO) Announces FDA Approval Of IONSYS (Fentanyl Iontophoretic Transdermal System) For The Management Of Acute Post-Operative Pain For Adult Patients In The Hospital 5/1/2015 10:27:09 AM
The Medicines Company (MDCO) Announces FDA Approval Of RAPLIXA (Fibrin Sealant), The First And Only Powdered Fibrin Sealant Ready-To-Use For Mild To Moderate Surgical Bleeding 5/1/2015 10:24:42 AM
The Medicines Company (MDCO) To Announce First Quarter Financial Results On Tuesday, May 5, 2015 4/21/2015 11:38:29 AM
The Medicines Company (MDCO) Release: FDA Approves New Formulation Of MINOCIN (Minocycline) For Injection 4/20/2015 11:17:38 AM
FDA Advisory Committee Recommends Approval Of The Medicines Company (MDCO)'s Antiplatelet Therapy Cangrelor 4/16/2015 5:58:15 AM
The Medicines Company (MDCO) Surges as FDA Panel Approves Once-Rejected Blood Clot Preventer 4/16/2015 5:55:56 AM
The Medicines Company (MDCO) Stock Trading Halted Today 4/15/2015 12:30:07 PM
12345678910...